Weiyan Cheng
Impact in
-
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
Papers in
- Oncology 10
- HER2/EGFR in Cancer Research 4
-
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Xin Tian (11 shared papers)Xiaojian Zhang (9 shared papers)Wei Han (6 shared papers)Zhiheng Yang (7 shared papers)Suhua Wang (4 shared papers)Quancheng Kan (3 shared papers)Yueqin Wang (3 shared papers)Ying Li (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (7 papers)Bioorganic Chemistry (3 papers)Bioorganic & Medicinal Chemistry (3 papers)Current Medicinal Chemistry (2 papers)Sensors and Actuators B Chemical (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Weiyan Cheng
26 papers receiving 561 citations
Peers
Comparison fields: 5 of 72
- Oncology 152
- Molecular Medicine 28
- Molecular Biology 334
- Process Chemistry and Technology 13
- Organic Chemistry 122
Countries citing papers authored by Weiyan Cheng
This map shows the geographic impact of Weiyan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyan Cheng more than expected).
Fields of papers citing papers by Weiyan Cheng
This network shows the impact of papers produced by Weiyan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyan Cheng. The network helps show where Weiyan Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiyan Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 102 | |
| 2 | 2019 | 95 | |
| 3 | 2019 | 52 | |
| 4 | 2021 | 41 | |
| 5 | 2016 | 33 | |
| 6 | 2017 | 32 | |
| 7 | 2014 | 29 | |
| 8 | 2023 | 28 | |
| 9 | 2020 | 25 | |
| 10 | 2014 | 19 | |
| 11 | 2018 | 18 | |
| 12 | 2019 | 16 | |
| 13 | 2020 | 14 | |
| 14 | 2016 | 14 | |
| 15 | 2019 | 9 | |
| 16 | 2014 | 9 | |
| 17 | Design, Synthesis, and Biological Evaluation of 2-Anilino-4-Triazolpyrimidine Derivatives as CDK4/HDACs Inhibitors | 2022 | 9 |
| 18 | 2021 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2023 | 5 |
About Weiyan Cheng
Weiyan Cheng is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Cell Biology, having authored 28 papers that have together received 572 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Protein Degradation and Inhibitors (4 papers), HER2/EGFR in Cancer Research (4 papers), Lung Cancer Treatments and Mutations (4 papers), Advanced Breast Cancer Therapies (3 papers), Ubiquitin and proteasome pathways (3 papers), Chemical Reactions and Isotopes (2 papers) and Asymmetric Hydrogenation and Catalysis (2 papers). The work is most often cited by research in Oncology (152 citations), Molecular Medicine (28 citations), Molecular Biology (334 citations), Process Chemistry and Technology (13 citations) and Organic Chemistry (122 citations). Weiyan Cheng has collaborated with scholars based in China and United States. Frequent co-authors include Xin Tian, Xiaojian Zhang, Wei Han, Zhiheng Yang, Suhua Wang, Quancheng Kan, Yueqin Wang, Ying Li, Shasha Li and Yongzhou Hu. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic Chemistry, Bioorganic & Medicinal Chemistry, Current Medicinal Chemistry and Sensors and Actuators B Chemical.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.